Hui Chen

Advances in Targeting HER2 across Cancer Subtypes: A Pan-Tumor Approach

Taiwo Adesoye, Ecaterina E. Dumbrava, Kanwal Raghav, Ayşegül A. Şahin et autres

us (code pays fourni par la source)

TRPS1 expression in neuroendocrine neoplasms of breast and other organs

Qiqi Ye, Jeannelyn S. Estrella, Neda Kalhor, Audrey Liu et autres

us (code pays fourni par la source)

Abstract P3-03-17: Genetic Profiles and Precision Medicine in Adolescent and Young Adult Chinese Women with Breast Cancer: A Comprehensive Study

Qing Hao, Fei Pang, Chengyi Wang, Hongrui Zhou et autres

Abstract P5-02-24: Targeting FOXK2 signaling in breast cancers with FOXK2 amplification/overexpression and PIK3CA oncogenic mutations: a promising therapeutic strategy?

Hong Zhang, Yang Yu, Feng Cheng, Edaise da Silva et autres

OS-073 Entry inhibitor Hepalatide combined with pegylated interferonalpha 2a therapy resulted in cccDNA clearance in CHB patients: a phase II randomised, double-blind, placebo-controlled trial

Junliang Fu, Qing Mao, Qinglong Jin, Hui Chen et autres

Supplementary Table S1 from Human Epidermal Growth Factor Receptor 2 Loss following Treatment with Trastuzumab Deruxtecan in Patients with Metastatic Breast Cancer

Mohamed A. Gouda, Amrit S. Gonugunta, Ecaterina E. Dumbrava, Timothy A. Yap et autres

Supplementary Table S4 from Human Epidermal Growth Factor Receptor 2 Loss following Treatment with Trastuzumab Deruxtecan in Patients with Metastatic Breast Cancer

Mohamed A. Gouda, Amrit S. Gonugunta, Ecaterina E. Dumbrava, Timothy A. Yap et autres

Supplementary Table S2 from Human Epidermal Growth Factor Receptor 2 Loss following Treatment with Trastuzumab Deruxtecan in Patients with Metastatic Breast Cancer

Mohamed A. Gouda, Amrit S. Gonugunta, Ecaterina E. Dumbrava, Timothy A. Yap et autres

Data from Human Epidermal Growth Factor Receptor 2 Loss following Treatment with Trastuzumab Deruxtecan in Patients with Metastatic Breast Cancer

Mohamed A. Gouda, Amrit S. Gonugunta, Ecaterina E. Dumbrava, Timothy A. Yap et autres

Supplementary Table S3 from Human Epidermal Growth Factor Receptor 2 Loss following Treatment with Trastuzumab Deruxtecan in Patients with Metastatic Breast Cancer

Mohamed A. Gouda, Amrit S. Gonugunta, Ecaterina E. Dumbrava, Timothy A. Yap et autres

441 Clinicopathologic and Molecular Characterization of BRAF-Fused Melanomas: A Retrospective Analysis of 9 Cases with 8 Novel Fusions Detected by Next-Generation Sequencing

Elsayed Ibrahim, Richard K. Yang, Priya Nagarajan, Keith Sweeney et autres

750 GATA3 and TRPS1 Expression in Follicular Dendritic Cell Sarcoma

Liangli Wang, Hui Chen, Anna Fei, Y. Zhang et autres

us (code pays fourni par la source)